Master cross-border taxation, transfer pricing compliance, and global entity structuring for startups with expert guidance from Altevius Partners.

Understand how to defend intra-group service charges through the benefit test, arm's length pricing, and robust documentation to reduce transfer pricing audit risks.

Compare UAE transfer pricing documentation costs vs FTA penalties. Discover ROI, risks, and smart compliance strategies.

India’s High Court of Bombay ordered income tax officials to refund about $132 million to mobile network operator Vodafone Idea Ltd.

In new Income Tax Bill, proposed changes to beneficial ownership tests could deny loss carry forwards for start-ups with complex funding structures. #Incometax #startups

𝐀 𝐛𝐢𝐠 𝐦𝐢𝐥𝐞𝐬𝐭𝐨𝐧𝐞 𝐢𝐧 𝐀𝐢𝐛𝐢𝐝𝐢𝐚’𝐬 𝐣𝐨𝐮𝐫𝐧𝐞𝐲 - 𝐚𝐧𝐝 𝐨𝐧𝐞 𝐈 𝐚𝐦 𝐭𝐫𝐮𝐥𝐲 𝐠𝐫𝐚𝐭𝐞𝐟𝐮𝐥 𝐭𝐨 𝐰𝐢𝐭𝐧𝐞𝐬𝐬 𝐮𝐩 𝐜𝐥𝐨𝐬𝐞. Today, I am excited to share that we have raised $𝟮𝟴𝐌 𝐢𝐧 𝐒𝐞𝐫𝐢𝐞𝐬 𝐁 𝐟𝐮𝐧𝐝𝐢𝐧𝐠 to accelerate our expansion into the ...

Volgens Microsoft heeft de IRS gekeken naar zogenoemde transferpricing in de periode 20042013 een belastingconstructie waarbij een multinational zijn winsten handig verdeelt over landen waar die gevestigd is

Wetenschappers zeggen in gehackte documenten te hebben ontdekt hoe het Shell lukt in Nederland geen belasting te betalen: door aan buitenlandse dochterbedrijven diensten te verlenen onder de marktprij...

Musk's X Corp. AI expansion plans for Atlanta stymied by deadlocked vote on $10.1…

The Canada Revenue Agency (CRA) is conducting an ongoing audit of Eli Lilly Canada's tax practices, focusing on potential transfer pricing issues. Federal court filings reveal the CRA launched an audit in 2024 after noticing suspiciously low profit margins for the U.S.-based pharmaceutical giant in 2020. The agency alleges that Lilly Canada acquired most of its inventory from related offshore entities, primarily Ireland, a low-tax jurisdiction. This has raised concerns about whether the company underpaid taxes by artificially lowering prices for transactions with its foreign subsidiaries. The CRA's lawsuit, filed in July 2026, seeks court orders to obtain undisclosed documents related to intercompany transactions involving distribution, marketing, clinical research, and support services. While the audit is still ongoing and no wrongdoing has been publicly confirmed, the case highlights the complexities of transfer pricing regulations in Canada, which aim to prevent profit shifting across borders. Tax experts note that multinational pharmaceutical companies like Lilly are prime targets for CRA audits due to the scale of their intercompany transactions. The dispute underscores the high-stakes nature of tax investigations involving major corporations and the potential for significant financial implications.